Amit Agarwal

Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer

David Miles, Joseph Gligorov, Fabrice André et al. · Annals of Oncology · 2021 · 689 citations · Full text

Screening of over 1000 Indian patients with breast and/or ovarian cancer with a multi-gene panel: prevalence of BRCA1/2 and non-BRCA mutations

Jaya Singh, Nishita Thota, Suhasini Singh et al. · Breast Cancer Research and Treatment · 2018 · 93 citations

Indian Patients, Breast Oncology, Medicine +10

Association of Polymorphisms in Base Excision Repair Genes With the Risk of Breast Cancer: A Case-Control Study in North Indian Women

Amit Mitra, Neetu Singh, Ashok K. Singh et al. · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · 2008 · 47 citations · Full text

Breast Oncology, Cancer Pathology, Genetics +16

Prevalence of <i>BRCA1</i> and <i>BRCA2</i> Mutations Among Patients With Ovarian, Primary Peritoneal, and Fallopian Tube Cancer in India: A Multicenter Cross-Sectional Study

Sudeep Gupta, Senthil Rajappa, Suresh H. Advani et al. · JCO Global Oncology · 2021 · 38 citations · Full text

PARP Inhibitor in Platinum-Resistant Ovarian Cancer: Single-Center Real-World Experience

Amit Agarwal, Saphalta Baghmar, Chandragouda Dodagoudar et al. · JCO Global Oncology · 2021 · 21 citations · Full text